These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1971640)

  • 1. Challenges in the design of trials to evaluate antibacterial agents in serious infections.
    Norrby SR
    J Hosp Infect; 1990 Apr; 15 Suppl A():13-21. PubMed ID: 1971640
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
    Hartenauer U; Weilemann LS; Bodmann KF; Ritzerfeld WW; Asmus S; Koch EM
    J Hosp Infect; 1990 Apr; 15 Suppl A():61-4. PubMed ID: 1971647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
    Norrby SR; Finch RG; Glauser M
    J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
    Vazquez JA; González Patzán LD; Stricklin D; Duttaroy DD; Kreidly Z; Lipka J; Sable C
    Curr Med Res Opin; 2012 Dec; 28(12):1921-31. PubMed ID: 23145859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients.
    Liu CY; Wang FD
    Chemotherapy; 1989; 35 Suppl 2():16-22. PubMed ID: 2692982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
    Sims M; Mariyanovski V; McLeroth P; Akers W; Lee YC; Brown ML; Du J; Pedley A; Kartsonis NA; Paschke A
    J Antimicrob Chemother; 2017 Sep; 72(9):2616-2626. PubMed ID: 28575389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients.
    Cox CE; Holloway WJ; Geckler RW
    Clin Infect Dis; 1995 Jul; 21(1):86-92. PubMed ID: 7578765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
    Ho A; Leung R; Lai CK; Chan TH; Chan CH
    Respiration; 1997; 64(3):224-8. PubMed ID: 9154675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
    Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group.
    Romanelli G; Cravarezza P
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():109-19. PubMed ID: 8543487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing role of carbapenems in the treatment of lower respiratory tract infections.
    Lode H; Hamacher J; Eller J; Schaberg T
    Scand J Infect Dis Suppl; 1995; 96():17-23. PubMed ID: 7652498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
    Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S
    Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections.
    Jia B; Lu P; Huang W; Li C; Huang A; Zhou X; Zhang W; Wu G; Zhang G
    Chemotherapy; 2010; 56(4):285-90. PubMed ID: 20714145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of imipenem/cilastatin (Tienam, MSD) in treating complicated infections in urology].
    Derevianko II; Nefedova LA; Lavrinova LN
    Urologiia; 2002; (3):21-5. PubMed ID: 12180053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection.
    Singh KP; Li G; Mitrani-Gold FS; Kurtinecz M; Wetherington J; Tomayko JF; Mundy LM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5284-90. PubMed ID: 23939900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin in the treatment of severe nosocomial pneumonia.
    Potgieter PD; Linton DM; Forder AA; Plumb H
    S Afr Med J; 1988 Oct; 74(8):390-2. PubMed ID: 3187816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
    Sakka SG; Glauner AK; Bulitta JB; Kinzig-Schippers M; Pfister W; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3304-10. PubMed ID: 17620371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem + cilastatin--a new type of antibiotic.
    Drug Ther Bull; 1991 May; 29(11):43-4. PubMed ID: 1935582
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
    Tsuchimori N; Yamazaki T; Okonogi K
    J Antimicrob Chemother; 1997 Mar; 39(3):423-5. PubMed ID: 9096195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenems.
    Schlossberg D; Pietroski N
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):4. PubMed ID: 12118842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.